GLIPAZIN 10

Dapagliflozin 10mg

DAPAGLIFLOZIN

Selective sodium-glucose co-transporter type 2 inhibitor (iSGLT2), blocks glucose re-absorption in the proximal tubule of the kidney
Increases urinary glucose excretion and reduces blood glucose levels
Enables sustained reductions in HbAlc, FPG and weight without increasing the risk of hypoglycemia in patients with type 2 diabetes
Monotherapy in reduction of FPG (fasting plasma glucose)

Sodium Glucose co transporters 2 inhibitors(SGLT-2)